No trading action warranted. This is a routine administrative filing reflecting standard employee share scheme issuances. Monitor for any future material filings such as earnings or pipeline updates.
AZN drugs
AZN drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 1 $162.22entry
- T+1 · 3mo ago −0.58%α −1.02% · $161.28
- T+5 · 2mo ago −3.25%α −3.33% · $156.94
- T+20 · 7w ago −0.46%α −0.57% · $161.47
- T+53 · todayOpen
- T+60 · in 8d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
AstraZeneca filed a routine 6-K notification of admission of 10,072 ordinary shares to trading on the London Stock Exchange, issued under the company's employee share schemes between 1 August 2026 and 31 August 2026. The total shares in issue post-admission is 1,551,043,461. This is a standard administrative filing with no material financial or operational impact, representing dilution of less than 0.001% of outstanding shares.
Key Facts
- 10,072 ordinary shares of $0.25 each were admitted to trading on the London Stock Exchange.
- Shares were issued under employee share schemes between 1 August 2026 and 31 August 2026.
- Total shares in issue after admission: 1,551,043,461.
- The new shares are fully fungible with existing ordinary shares.
Financial Impact
Dilution of approximately 0.00065% of outstanding shares, negligible economic impact.
Risk Factors
- None identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (AZN), Batch item 1 | 0001654954-26-008042 |
| Document: 0001654954-26-008042-index-headers.html | 0001654954-26-008042 |
| Document: 0001654954-26-008042-index.html | 0001654954-26-008042 |
| Document: 0001654954-26-008042.txt | 0001654954-26-008042 |
| 6-K Filing (AZN), Batch item 5 | 0001654954-26-008042 |
| Document: 0001654954-26-008042-index-headers.html | 0001654954-26-008042 |
| Document: 0001654954-26-008042-index.html | 0001654954-26-008042 |
| Document: 0001654954-26-008042.txt | 0001654954-26-008042 |
Track record
77 reports on AZN
19 of 38 bullish or bearish reports moved the stock their way by T+5. Best: +20.72% at T+60 after the Aug 17, 2026 report. 29 of 38 went positive at some point.
Filters
- Nov 16, 2026today 6-K Bullish 6/10 Entry price pending
- Nov 16, 2026today 6-K Bullish 6/10 Entry $185.55 Now $184.45 −0.59% settles Nov 23
- Nov 16, 2026today 6-K Bullish 6/10 Entry $185.31 Now $184.45 −0.46% settles Nov 23
- Nov 16, 2026today 6-K Bullish 5/10 Entry $185.09 Now $184.45 −0.35% settles Nov 23
- Nov 4, 202612d ago Institutional Cluster Mixed 3/10 Entry $186.85 to $184.38 Now $184.45 −1.28% ▼ −1.32% −4.61% vs SPY
- Nov 2, 202614d ago 6-K Neutral 1/10 Entry $186.58 to $189.39 Now $184.45 −1.14% ▲ +1.51% +1.43% vs SPY
- Nov 2, 202614d ago 6-K Neutral 1/10 Entry $186.58 to $189.39 Now $184.45 −1.14% ▲ +1.51% +1.43% vs SPY
- Oct 30, 202617d ago 6-K Neutral 5/10 Entry $186.65 to $186.43 Now $184.45 −1.18% ▼ −0.12% +2.59% vs SPY
- Oct 27, 202620d ago 6-K Bullish 5/10 Entry $170.08 to $183.88 Now $184.45 +8.45% ▲ +8.11% +10.10% vs SPY
- Oct 22, 202625d ago 6-K Bullish 6/10 Entry $172.57 to $173.46 Now $184.45 +6.88% ▲ +0.51% −0.19% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers